Managennent of latent Mycobacterium tuberculosis infection: WHO guidelines for Low tuberculosis burden countries

Haileyesus Getahun; Alberto Matteelli; Ibrahim Abubakar; Mohamed Abdel Aziz; Annabel Baddeley; Draurio Barreira; Saskia Den Boon; Susana Marta Borroto Gutierrez; Judith Bruchfeld; Edina Burhan; Solange Cavalcante; Rolando Cedillos; Richard Chaisson; Cynthia Bin-Eng Chee; Lucy Chesire; Elizabeth Corbett; Masoud Dara; Justin Denholm; Gerard de Vries; Dennis Falzon; Nathan Ford; Margaret Gale-Rowe; Chris Gilpin; Enrico Girardi; Un-Yeong Go; Darshini Govindasamy; Alison D. Grant; Malgorzata Grzemska; Ross Harris; C. Robert Horsburgh; Asker Ismayilov; Ernesto Jaramillo; Sandra Kik; Katharina Kranzer; Christian Lienhardt; Philip LoBue; Knut Loennroth; Guy Marks; Dick Menzies; Giovanni Battista Migliori; Davide Mosca; Ya Diul Mukadi; Alwyn Mwinga; Lisa Nelson; Nobuyuki Nishikiori; Anouk Oordt-Speets; Molebogeng Xheedha Rangaka; Andreas Reis; Lisa Rotz; Andreas Sandgren; Monica Sane Schepisi; Holger J. Schuenemann; Surender Kumar Sharma; Giovanni Sotgiu; Helen R. Stagg; Timothy R. Sterling; Tamara Tayeb; Mukund Uplekar; Marieke J. van der Werf; Wim Vandevelde; Femke van Kessel; Anna van't Hoog; Jay K. Varma; Natalia Vezhnina; Constantia Voniatis; Marije Vonk Noordegraaf-Schouten; Diana Weil; Karin Weyer; Robert John Wilkinson; Takashi Yoshiyama; Jean Pierre Zellweger; Mario Raviglione

doi:10.1183/13993003.01245-2015

Retour

Managennent of latent Mycobacterium tuberculosis infection: WHO guidelines for Low tuberculosis burden countries

Article de revue

Avec comité de lecture

Managennent of latent Mycobacterium tuberculosis infection: WHO guidelines for Low tuberculosis burden countries

Haileyesus Getahun, Alberto Matteelli, Ibrahim Abubakar, Mohamed Abdel Aziz, Annabel Baddeley, Draurio Barreira, Saskia Den Boon, Susana Marta Borroto Gutierrez, Judith Bruchfeld, Edina Burhan, …

The European respiratory journal, Vol.46(6), pp.1563-1576

01/12/2015

DOI: https://doi.org/10.1183/13993003.01245-2015

PMID: 26405286

Résumé

Life Sciences & Biomedicine

Respiratory System

Science & Technology

Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses to previously acquired Mycobacterium tuberculosis infection without clinical evidence of active tuberculosis (TB). Here we report evidence-based guidelines from the World Health Organization for a public health approach to the management of LTBI in high risk individuals in countries with high or middle upper income and TB incidence of <100 per 100 000 per year. The guidelines strongly recommend systematic testing and treatment of LTBI in people living with HIV, adult and child contacts of pulmonary TB cases, patients initiating anti-tumour necrosis factor treatment, patients receiving dialysis, patients preparing for organ or haematological transplantation, and patients with silicosis. In prisoners, healthcare workers, immigrants from high TB burden countries, homeless persons and illicit drug users, systematic testing and treatment of LTBI is conditionally recommended, according to TB epidemiology and resource availability. Either commercial interferon-gamma release assays or Mantoux tuberculin skin testing could be used to test for LTBI. Chest radiography should be performed before LTBI treatment to rule out active TB disease. Recommended treatment regimens for LTBI include: 6 or 9 month isoniazid; 12 week rifapentine plus isoniazid; 3-4 month isoniazid plus rifampicin; or 3-4 month rifampicin alone.

Indicateurs

1 Consultations de la notice

See more details

Détails

Titre: Managennent of latent Mycobacterium tuberculosis infection: WHO guidelines for Low tuberculosis burden countries
Créateurs - sans rôle: Haileyesus Getahun - WHO, Global TB Programme, 20 Ave Appia, CH-1211 Geneva, Switzerland
Alberto Matteelli - WHO, Global TB Programme, 20 Ave Appia, CH-1211 Geneva, Switzerland
Ibrahim Abubakar - UCL, Dept Infect & Populat Hlth, London, England
Mohamed Abdel Aziz - WHO, Reg Off Eastern Mediterranean, Cairo, Egypt
Annabel Baddeley - WHO, Global TB Programme, 20 Ave Appia, CH-1211 Geneva, Switzerland
Draurio Barreira - Minist Hlth, Natl TB Programme, Brasilia, DF, Brazil
Saskia Den Boon
Susana Marta Borroto Gutierrez - Pedro Kourf Inst Trop Med, Havana, Cuba
Judith Bruchfeld - Karolinska Institutet
Edina Burhan - Univ Indonesia, Fac Med, Dept Pulmonol & Resp Med, Jakarta, Indonesia
Solange Cavalcante - Fiocruz MS, Evandro Chagas Natl Inst Infect Dis, BR-21045900 Rio De Janeiro, Brazil
Rolando Cedillos - Hosp Nacl Rosales, San Salvador, El Salvador
Richard Chaisson - Johns Hopkins University
Cynthia Bin-Eng Chee - Tan Tock Sang Hosp, Singapore, Singapore
Lucy Chesire - TB Advocacy Consortium, Nairobi, Kenya
Elizabeth Corbett - London Sch Hyg & Trop Med, Blantyre, Malawi
Masoud Dara - WHO, Reg Off Europe, Copenhagen, Denmark
Justin Denholm - Victorian TB Program, Melbourne, Vic, Australia
Gerard de Vries - KNCV TB Fdn, The Hague, Netherlands
Dennis Falzon - WHO, Global TB Programme, 20 Ave Appia, CH-1211 Geneva, Switzerland
Nathan Ford - WHO, Dept HIV & Global Hepatitis Programme, Geneva, Switzerland
Margaret Gale-Rowe - Publ Hlth Agcy Canada, Ottawa, ON, Canada
Chris Gilpin - WHO, Global TB Programme, 20 Ave Appia, CH-1211 Geneva, Switzerland
Enrico Girardi - Ist Nazl Malattie Infett L Spallanzani, Rome, Italy
Un-Yeong Go - Korea Ctr Dis Control & Prevent, Dept HIV AIDS & TB Control Korea, Seoul, South Korea
Darshini Govindasamy - South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa
Alison D. Grant - London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England
Malgorzata Grzemska - WHO, Global TB Programme, 20 Ave Appia, CH-1211 Geneva, Switzerland
Ross Harris - Publ Hlth England, London, England
C. Robert Horsburgh - Boston University
Asker Ismayilov - Minist Justice, Main Med Dept, Baku, Azerbaijan
Ernesto Jaramillo - WHO, Global TB Programme, 20 Ave Appia, CH-1211 Geneva, Switzerland
Sandra Kik - McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada
Katharina Kranzer - London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England
Christian Lienhardt - WHO, Global TB Programme, 20 Ave Appia, CH-1211 Geneva, Switzerland
Philip LoBue - Ctr Dis Control & Prevent, Atlanta, GA USA
Knut Loennroth - WHO, Global TB Programme, 20 Ave Appia, CH-1211 Geneva, Switzerland
Guy Marks - The University of Sydney
Dick Menzies - McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada
Giovanni Battista Migliori - WHO, Collaborating Ctr TB & Lung Dis Fdn S Maugeri, Tradate, Italy
Davide Mosca - Int Org Migrat, Migrat Hlth Dept, Geneva, Switzerland
Ya Diul Mukadi - US Agcy Int Dev, Div Infect Dis, Bur Global Hlth, Washington, DC 20523 USA
Alwyn Mwinga - Zambart Project, Lusaka, Zambia
Lisa Nelson - WHO, Dept HIV & Global Hepatitis Programme, Geneva, Switzerland
Nobuyuki Nishikiori - WHO, Reg Off Western Pacific, Manila, Philippines
Anouk Oordt-Speets - Paltas Hlth Res & Consultancy BV, Rotterdam, Netherlands
Molebogeng Xheedha Rangaka - UCL, Dept Infect & Populat Hlth, London, England
Andreas Reis - WHO, Knowledge Eth & Res Dept, Geneva, Switzerland
Lisa Rotz - Ctr Dis Control & Prevent, Atlanta, GA USA
Andreas Sandgren - European Ctr Dis Prevent & Control, Stockholm, Sweden
Monica Sane Schepisi - Ist Nazl Malattie Infett L Spallanzani, Rome, Italy
Holger J. Schuenemann - McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
Surender Kumar Sharma - WHO, Knowledge Eth & Res Dept, Geneva, Switzerland
Giovanni Sotgiu - European Ctr Dis Prevent & Control, Stockholm, Sweden
Helen R. Stagg - UCL, Dept Infect & Populat Hlth, London, England
Timothy R. Sterling - Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
Tamara Tayeb - Minist Hlth, Natl TB Programme, Riyadh, Saudi Arabia
Mukund Uplekar - WHO, Global TB Programme, 20 Ave Appia, CH-1211 Geneva, Switzerland
Marieke J. van der Werf - European Ctr Dis Prevent & Control, Stockholm, Sweden
Wim Vandevelde - European AIDS Treatment Grp, Brussels, Belgium
Femke van Kessel - Paltas Hlth Res & Consultancy BV, Rotterdam, Netherlands
Anna van't Hoog - Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands
Jay K. Varma - Ctr Dis Control & Prevent, Atlanta, GA USA
Natalia Vezhnina - HIV TB & Penal Syst Projects, Moscow, Russia
Constantia Voniatis - Minist Hlth, Clin Labs, Nicosia, Cyprus
Marije Vonk Noordegraaf-Schouten - Paltas Hlth Res & Consultancy BV, Rotterdam, Netherlands
Diana Weil - WHO, Global TB Programme, 20 Ave Appia, CH-1211 Geneva, Switzerland
Karin Weyer - WHO, Global TB Programme, 20 Ave Appia, CH-1211 Geneva, Switzerland
Robert John Wilkinson - Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa
Takashi Yoshiyama - Japan Anti TB Assoc, Fukujuji Hosp, Tokyo, Japan
Jean Pierre Zellweger - TB Competence Ctr, Bern, Switzerland
Mario Raviglione - WHO, Global TB Programme, 20 Ave Appia, CH-1211 Geneva, Switzerland
Détails de publication: The European respiratory journal, Vol.46(6), pp.1563-1576
Éditeur: European Respiratory Soc Journals Ltd
Nombre de pages: 14
Note de subvention: 104803/Z/14/Z / Wellcome Trust 10218 / The Francis Crick Institute SRF-2011-04-001 / National Institute for Health Research; National Institutes of Health Research (NIHR) SRF-2011-04-001 / National Institutes of Health Research (NIHR)
Identifiants: 99158545409311
Unité académique: Recherches translationnelles sur le VIH et les Maladies Infect. Endém. émerg. - TransVIHMI
Langue: English
Type de ressource: Journal article